The prognosis for unresectable melanoma depends on various factors including the extent of disease spread, the patient's overall health, and how well the cancer responds to treatment. While the prognosis is generally less favorable than for resectable melanoma, advancements in treatments such as immunotherapy and targeted therapy have significantly improved outcomes for many patients.
